Dendrobium officinale polysaccharide-containing senescence-delaying composition as well as preparation method and application thereof

Through the synergistic effect of Dendrobium officinalis polysaccharide and spermidine, the use concentration of Dendrobium officinalis polysaccharide was reduced, and the problem of poor effect at low concentrations was solved. The effect of delaying aging was verified through the experiment of C. elegans, and the effect of delaying aging was achieved at low concentrations. The effect of anti-aging and preventing age-related diseases is significant.

CN119015303APending Publication Date: 2024-11-26JIANGNAN UNIV
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411072260.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-06
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The efficacy of Dendrobium officinale polysaccharide is closely related to its dosage, and high concentrations are significant. However, due to its high price, how to achieve good results at low concentrations is an urgent problem that needs to be solved, affecting its widespread application in health products.

Method used

Through synergistic effects with spermidine, the concentration of Dendrobium officinalis polysaccharide was reduced, and its efficacy was verified through the aging experiment of C. elegans. The compositions include Dendrobium officinalis polysaccharide and spermidine, with concentrations of 240-260 mg/L and 25 respectively. ~35 mg/L, the solvent is water or an aqueous ethanol solution, and the auxiliary materials may include nutrients, functional additives and flavor additives.

Benefits of technology

Effectively extend the lifespan of C. elegans, significantly increase their survival time under oxidative and thermal stress, the synergistic index CI is 0.65 and 0.33, which significantly affects the level of metabolites and prevents age such as Alzheimer's disease and Parkinson's disease. Related diseases, and the composition is safe and reliable, with reduced use but significant effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119015303A_ABST
    Figure CN119015303A_ABST
Patent Text Reader

Abstract

The invention discloses an anti-aging composition containing dendrobium officinale polysaccharide as well as a preparation method and application of the anti-aging composition, and belongs to the field of health-care products. The composition comprises dendrobium officinale polysaccharide and spermidine, the concentration of the dendrobium officinale polysaccharide in the composition is 240-260 mg / L, and the concentration of the spermidine in the composition is 25-35 mg / L. The composition prepared by the invention is safe, reliable, simple to prepare and easy to implement. Meanwhile, the use amount of the dendrobium officinale polysaccharide can be remarkably reduced through the synergistic effect of the dendrobium officinale polysaccharide composition, so that the dendrobium officinale polysaccharide can achieve the effect when the use amount of the dendrobium officinale polysaccharide is 250 mg / L and the use amount of the dendrobium officinale polysaccharide is 500 mg / L at ordinary times.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to an anti-aging composition containing dendrobium officinale polysaccharide and a preparation method and application thereof, belonging to the field of health care products. Background Art

[0002] In the context of an aging population structure, there is an urgent need to explore effective strategies to slow down the aging process, prevent age-related diseases, and improve the quality of life. Dietary interventions are recognized for their safety, effectiveness, wide applicability, and cost-effectiveness, and may extend lifespan or maintain health by regulating nutritional signals, gut microbiota composition, and energy metabolism. Dendrobium officinale (DO) is a traditional functional food that has received increasing attention. Its main active ingredient, Dendrobium officinale polysaccharide (DOP), has a content of up to 36.30%, and the yield after water extraction and alcohol precipitation is more than 20%. Increasing evidence shows that DOP has antioxidant, immunomodulatory, anti-aging, anti-tumor, and hypoglycemic abilities. However, DOP is expensive and usually requires a higher concentration to function well, so it is necessary to study how to reduce its effective concentration and explore its synergistic effects.

[0003] The long-standing successful application of herbal combinations has prompted the investigation of the synergistic potential of phytochemicals with health-promoting properties. In contemporary medical research, the evaluation of synergistic effects is key to improving therapeutic efficacy and affecting multiple biological targets simultaneously. Individual dietary supplements often exert anti-aging effects through one or two different pathways, therefore, the synergistic application of multiple supplements may produce additive therapeutic effects. Caloric restriction (CR) has been shown to effectively extend healthy lifespan. Caloric restriction mimetics (CRMs) activate beneficial pathways associated with CR and avoid the subjective discomfort commonly associated with CR or intermittent fasting. CRMs can promote protein deacetylation and promote autophagy, thereby delaying aging. Summary of the invention

[0004] Technical issues

[0005] The efficacy of Dendrobium officinale polysaccharide (DOP) is closely related to its dosage within a certain range. The higher the concentration, the more significant the effect. The concentration used is usually 500 mg / L. However, due to its high price, how to make it still play a good effect under low concentration conditions is a technical problem that needs to be solved urgently, which is of great significance for promoting its wide application in health products.

[0006] Technical Solution

[0007] In order to solve the above problems, the present invention aims to provide a Dendrobium officinale polysaccharide composition for delaying aging, and its preparation method and application, through the synergistic effect of DOP and spermidine (Spd), effectively reduce the use concentration of DOP, and prove its efficacy through experiments on delaying aging of Caenorhabditis elegans. In addition, spermidine as a synergistic component has a wide source, is safe and non-toxic, and is cheap.

[0008] The first object of the present invention is to provide a composition containing Dendrobium officinale polysaccharide, which comprises Dendrobium officinale polysaccharide and spermidine; the concentration of Dendrobium officinale polysaccharide in the composition is 240-260 mg / L, and the concentration of spermidine is 25-35 mg / L.

[0009] Preferably, the concentration of Dendrobium officinale polysaccharide in the composition is 250 mg / L.

[0010] Preferably, the concentration of spermidine in the composition is 29 mg / L.

[0011] Furthermore, the solvent of the composition includes water and ethanol aqueous solution.

[0012] Furthermore, the ethanol concentration in the ethanol aqueous solution does not exceed 30% vol.

[0013] Furthermore, the composition may further include auxiliary materials.

[0014] Furthermore, the auxiliary materials include one or more of nutrients, functional additives, and flavor additives.

[0015] Furthermore, nutrients include one or more of macronutrients and micronutrients.

[0016] Furthermore, the functional additives include one or more of an emulsifier, a stabilizer and a preservative.

[0017] Furthermore, the flavor additives include one or more of sweeteners and natural flavors.

[0018] Furthermore, the preparation method of the Dendrobium officinale polysaccharide is as follows:

[0019] The powder of Dendrobium officinale is defatted, and then it is washed with ethanol to remove impurities. The washed powder of Dendrobium officinale is extracted with hot water, and the obtained extract is precipitated with an ethanol aqueous solution; the precipitate obtained by centrifugation is resuspended and destarchized with a heat-resistant α-amylase, and then freeze-thaw centrifugation is performed; the obtained supernatant is dialyzed, and then the dialyzate is precipitated with an ethanol aqueous solution, and the precipitate is collected and freeze-dried to obtain Dendrobium officinale polysaccharide.

[0020] Furthermore, the degreasing is performed using n-hexane.

[0021] Furthermore, the temperature of the hot water extraction is 90-95°C.

[0022] Furthermore, the hot water extraction time is 4 to 6 hours.

[0023] Furthermore, the ethanol concentration in the ethanol aqueous solution is 60-80%.

[0024] Furthermore, the enzyme activity of the thermostable α-amylase is 15000-25000 U / mL.

[0025] Furthermore, the ratio of the mass of the precipitate to the volume of the thermostable α-amylase is 8-12 g:0.5 mL.

[0026] Furthermore, the dialysis is performed in a 3000-4000Da dialysis bag for 60-80 hours.

[0027] The present invention provides application of the composition in the field of medicine preparation, health care products or functional foods.

[0028] Furthermore, the drug is a drug that has the effect of delaying aging and preventing Alzheimer's disease and / or Parkinson's disease.

[0029] Furthermore, the health care product is a health care product that helps in anti-oxidation or assists in improving memory.

[0030] Furthermore, the health care product is prepared using the above composition and auxiliary materials.

[0031] Beneficial Effects

[0032] (1) The Dendrobium officinale polysaccharide composition prepared by the present invention can effectively prolong the life span of Caenorhabditis elegans. The average life span of the DS-HH group is 37.3% longer than that of the control group. When the mortality rate of the control group is 50%, the synergistic index CI of each group is 0.65, which has a synergistic effect. In addition, under the experiments of oxidative stress and heat stress, the average life span of Caenorhabditis elegans is increased by 109.6% and 52.1% respectively compared with the control group, and the synergistic index CI is 0.50 and 0.33 respectively, which has a synergistic effect.

[0033] (2) The polysaccharide composition of Dendrobium officinale prepared by the present invention can affect the metabolites of Caenorhabditis elegans. Compared with the control group, the contents of metabolites such as citric acid, 1-linoleoylglycerol, docosapentaenoic acid, β-nicotinamide mononucleotide, cyclic adenosine diphosphate ribose, UDP-galactose, 5-hydroxy-3-indoleacetic acid and taurine in the Caenorhabditis elegans in the DS-HH group increased significantly by more than 7 times, which fully demonstrated that the polysaccharide composition of Dendrobium officinale prepared by the present invention can play a good anti-aging effect and can also prevent age-related neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.

[0034] (3) The Dendrobium officinale polysaccharide composition prepared by the present invention is safe and reliable, simple to prepare and easy to implement. At the same time, the Dendrobium officinale polysaccharide composition of the present invention can significantly reduce the amount of Dendrobium officinale polysaccharide used through synergistic effect, so that the Dendrobium officinale polysaccharide can play the same effect as the usual 500 mg / L dosage at a dosage of 250 mg / L. BRIEF DESCRIPTION OF THE DRAWINGS

[0035] Figure 1 Fourier transform infrared spectrum of DOP (A) and triple helix structure (B);

[0036] Figure 2 Effects of the mixture of DOP, epigallocatechin gallate (EGCG) and caffeic acid (CA) on the lifespan of Caenorhabditis elegans under oxidative stress (A) and heat stress (B); *, p<0.05; **, p<0.01;

[0037] Figure 3 Effects of DOP, Spd and their mixture on the lifespan of Caenorhabditis elegans; *, p<0.05; **, p<0.01; ***, p<0.001;

[0038] Figure 4 Effects of DS-HH and 500 mg / L DOP on the lifespan of Caenorhabditis elegans; ns, no significant difference;

[0039] Figure 5 Effects of DOP, Spd and their mixture on the lifespan of Caenorhabditis elegans under oxidative stress; *, p<0.05; **, p<0.01; ***, p<0.001; ****, p<0.0001;

[0040] Figure 6 Effects of DOP, Spd and their mixture on the lifespan of Caenorhabditis elegans under heat stress; *, p<0.05; **, p<0.01; ***, p<0.001;

[0041] Figure 7 Effects of DOP, Spd and their mixture on the motility of Caenorhabditis elegans; *, p<0.05; **, p<0.01; ***, p<0.001; ****, p<0.0001;

[0042] Figure 8 Effects of DOP, Spd and their mixture on OPLS-DA analysis of the Caenorhabditis elegans metabolome. DETAILED DESCRIPTION

[0043] The preferred embodiments of the present invention are described below. It should be understood that the embodiments are for better explanation of the present invention and are not intended to limit the present invention. The raw materials used in the present invention are conventional commercial products unless otherwise specified; the methods used in the present invention are conventional methods in the art unless otherwise specified.

[0044] Source of raw materials

[0045] Dendrobium officinale powder was purchased from Zhejiang Juyoupin Biotechnology Co., Ltd.; spermidine (Spd) was purchased from Shanghai Yuanye Biotechnology Co., Ltd.; Caenorhabditis elegans was provided by the Caenorhabditis elegans Genetics Center of the United States.

[0046] Example 1

[0047] An anti-aging composition containing Dendrobium officinale polysaccharide:

[0048] S1. Preparation of DOP: 50 g of dried Dendrobium officinale powder was defatted with 500 mL of n-hexane, and then small molecular impurities were removed with 500 mL of 95% ethanol; the treated Dendrobium officinale powder was extracted with a 95°C hot water bath for 4 h, the extract was precipitated with 75% ethanol, the precipitate was freeze-dried, 10 g of the freeze-dried material was weighed and resuspended with 1 L of deionized water, and 0.5 mL of heat-resistant α-amylase (20000 U / mL) was added for destarch treatment, and after the enzymatic hydrolysis was completed, the reaction solution was frozen, thawed and centrifuged, the supernatant was taken and continued to freeze-thaw centrifugation, and the supernatant obtained was dialyzed with a dialysis bag with a molecular weight of 3500 Da for 72 h; the dialyzate obtained was precipitated with 75% ethanol again, and the precipitate was collected and freeze-dried to obtain DOP;

[0049] S2. Preparation of a polysaccharide composition of Dendrobium officinale: 125 mg of DOP prepared in step S1 was fully dissolved in 20 mL of water under magnetic stirring at 70-80° C. for 2-4 h, 14.5 mg of Spd was added and vortexed to fully mix, and the mass ratio of DOP to Spd was 125:14.5.

[0050] Example 2

[0051] The addition amount of Spd was adjusted to 29 mg, that is, the mass ratio of DOP to Spd was 125:29, and the other conditions were consistent with Example 1.

[0052] Example 3

[0053] The added amount of DOP was adjusted to 250 mg, that is, the mass ratio of DOP to Spd was adjusted to 250:14.5, and the other conditions were consistent with those in Example 1.

[0054] Example 4

[0055] The addition amount of DOP was adjusted to 250 mg, and the addition amount of Spd was adjusted to 29 mg, that is, the mass ratio of DOP to Spd was adjusted to 250:29, and the other conditions were consistent with Example 1.

[0056] Comparative Example 1

[0057] An anti-aging composition containing Dendrobium officinale polysaccharide:

[0058] S1. Preparation of DOP: the same as in Example 1.

[0059] S2. Preparation of a polysaccharide composition of Dendrobium officinale: 250 mg of DOP prepared in step S1 was fully dissolved in 20 mL of water under magnetic stirring at 70-80° C. for 2-4 h, 91.7 mg of epigallocatechin gallate (EGCG) was added and vortexed to fully mix, and the mass ratio of DOP to EGCG was 250:91.7.

[0060] Comparative Example 2

[0061] S1. Preparation of DOP: the same as in Example 1.

[0062] S2. Preparation of Dendrobium officinale polysaccharide composition: 250 mg of DOP prepared in step S1 was fully dissolved in 20 mL of water at 70-80° C. under magnetic stirring for 2-4 h, 36 mg of caffeic acid (CA) was added and vortexed to fully mix, and the mass ratio of DOP to CA was 250:36.0.

[0063] Experimental testing

[0064] (1) Characterization of DOP:

[0065] Fourier transform infrared spectroscopy (FTIR) results showed that 3390.2cm -1 The broad and strong band at 2931.3cm is the OH stretching vibration. -1 The peak at 1735.6cm is the CH stretching vibration of the CH2 group. -1 , 1415.5 and 1249.6cm -1 The bands represent the stretching vibration of the carbonyl bond (C=O), the -CH vibration of the -CH3 group, and the CO vibration, indicating the presence of the -O-COCH3 group. 1060.7 and 1029.8 cm -1 The prominent peak at 810.0 cm is attributed to the bending vibration mode of CO in the pyranose form. -1 The characteristic absorption peak at indicates the presence of α-pyranose chains ( Figure 1 A).

[0066] The results of high performance gel permeation chromatography (HPGPC) showed that the molecular weight of DOP was 324.54 kDa; the results of ion exchange chromatography showed that the molar ratio of the monosaccharide composition of DOP, mannose, glucose, galactose and arabinose, was 73.47:25.67:0.66:0.19, and it had a triple helix structure ( Figure 1 B).

[0067] (2) Caenorhabditis elegans experiment:

[0068] The composition described in Example 1 was dissolved in an Escherichia coli OP50 suspension, and the concentration of the composition was 139.5 mg / L, wherein the concentration of DOP was 125 mg / L, and the concentration of Spd was 14.5 mg / L, which was set as the DS-LL group.

[0069] The composition described in Example 2 was dissolved in an Escherichia coli OP50 suspension, and the concentration of the composition was 154 mg / L, wherein the concentration of DOP was 125 mg / L, and the concentration of Spd was 29 mg / L, which was set as the DS-LH group.

[0070] The composition described in Example 3 was dissolved in a suspension of Escherichia coli OP50, with a composition concentration of 264.5 mg / L, wherein the DOP concentration was 250 mg / L, and the Spd concentration was 14.5 mg / L, and this was designated as the DS-HL group.

[0071] The composition described in Example 4 was dissolved in an Escherichia coli OP50 suspension, and the concentration of the composition was 279 mg / L, wherein the concentration of DOP was 250 mg / L, and the concentration of Spd was 29 mg / L, which was set as the DS-HH group.

[0072] The composition described in Comparative Example 1 was dissolved in an Escherichia coli OP50 suspension, and the concentration of the composition was 341.7 mg / L, wherein the concentration of DOP was 250 mg / L, and the concentration of EGCG was 91.7 mg / L, which was set as a DOP-EGCG group.

[0073] The composition described in Comparative Example 2 was dissolved in an Escherichia coli OP50 suspension, and the concentration of the composition was 286 mg / L, wherein the concentration of DOP was 250 mg / L, and the concentration of CA was 36 mg / L, which was designated as a DOP-CA group.

[0074] DOP was dissolved in Escherichia coli OP50 suspension, with DOP concentrations of 125 mg / L, 250 mg / L and 500 mg / L, respectively, which were designated as DOP-L group, DOP-H group and DOP-500 group.

[0075] Spd was dissolved in Escherichia coli OP50 suspension, with Spd concentrations of 14.5 mg / L and 29 mg / L, respectively, which were designated as Spd-L group and Spd-H group.

[0076] NGM medium: 1L of culture medium contains 2.5g of peptone, 3.0g of sodium chloride, 0.111g of calcium chloride, 0.12g of magnesium sulfate, 0.005g of cholesterol, 0.89g of dipotassium hydrogen phosphate, 2.71g of potassium dihydrogen phosphate, and 17.0g of agar.

[0077] The concentration of Escherichia coli OP50 suspension is: 1.5OD.

[0078] Example 4

[0079] DOP synergizes with CRMs to enhance the anti-oxidative stress capacity of Caenorhabditis elegans

[0080] The synchronized L4 stage N2 wild-type Caenorhabditis elegans were transferred to NGM solid culture medium, and the Caenorhabditis elegans were intervened with the Escherichia coli OP50 suspension of the above-mentioned DOP-H group (DOP group), DS-HH group (DOP-Spd group), DOP-EGCG group and DOP-CA group for 3 days. Then, they were transferred to NGM culture medium containing 0.1% H2O2. The survival of the nematodes was observed and the number of surviving nematodes was recorded every 1 h until all the nematodes died (n=30). The survival rate and average lifespan of each group of nematodes under oxidative stress conditions were calculated, and the survival curve was drawn.

[0081] The control group was added with Escherichia coli OP50 suspension without DOP and Spd.

[0082] like Figure 2 As shown in A, under oxidative stress conditions, the lifespan of Caenorhabditis elegans in the DOP alone treatment group was 5.6 h, while the lifespans of Caenorhabditis elegans in the DOP-EGCG, DOP-CA and DOP-Spd treatment groups were 7.3 h, 6.0 h and 8.6 h, respectively. This shows that DOP-Spd performed best in improving the lifespan of Caenorhabditis elegans under oxidative stress conditions.

[0083] Example 5

[0084] DOP synergizes with CRMs to enhance the ability of Caenorhabditis elegans to resist high temperature stress

[0085] The synchronized L4 stage N2 wild-type Caenorhabditis elegans were transferred to NGM solid culture medium, and the Caenorhabditis elegans were intervened with the above-mentioned Escherichia coli OP50 suspensions of DOP-H group (DOP group), DS-HH group (DOP-Spd group), DOP-EGCG group and DOP-CA group for 3 days. Then, the Caenorhabditis elegans were placed in a 37°C incubator, and the survival of the nematodes was observed and the number of surviving nematodes was recorded every 1 h until all the nematodes died (n=30). The survival rate and average lifespan of the nematodes in each group under high temperature stress conditions were calculated, and the survival curve was drawn.

[0086] The control group was added with an Escherichia coli OP50 bacterial suspension without DOP and Spd.

[0087] As Figure 2 As shown in B, under high-temperature stress conditions, the lifespan of Caenorhabditis elegans in the DOP single-treatment group was 7.2 h, while the lifespans of Caenorhabditis elegans in the DOP-EGCG, DOP-CA, and DOP-Spd treatment groups were 7.7 h, 8.1 h, and 8.8 h, respectively. Thus, it can be seen that DOP-Spd performs best in improving the lifespan of Caenorhabditis elegans under high-temperature stress conditions.

[0088] Example 6

[0089] The enhancing effect of DOP in combination with Spd on the lifespan of Caenorhabditis elegans

[0090] The synchronized L4-stage N2 wild-type Caenorhabditis elegans were transferred to NGM solid medium. After 3 days of intervention with the above-mentioned Escherichia coli OP50 bacterial suspensions of the DS-LL group, DS-LH group, DS-HL group, DS-HH group, DOP-L group, DOP-H group, DOP-500 group, Spd-L group, and Spd-H group on Caenorhabditis elegans, they were then transferred to fresh NGM solid medium and placed in a 20 °C incubator. The fresh NGM solid medium was replaced every 2 days, and the survival of the nematodes was observed and the number of surviving nematodes was recorded until all the nematodes died (n = 30). The survival rate and average lifespan of the nematodes in each group were calculated, and the survival curves were plotted.

[0091] The control group was added with an Escherichia coli OP50 bacterial suspension without DOP and Spd.

[0092] The results are as Figure 3 shown. The DS-HH group had the best effect in extending the lifespan, with an average lifespan of 21.2 days, which was 37.3% higher than that of the control group. The mortality rates of each group were selected when the mortality rate of the control group was 50%, and the combination index CI was calculated to be 0.65 by CompuSyn software, indicating a synergistic effect. The combination index (CI) is an effective indicator for analyzing the synergistic potential of multi-component combinations at a fixed ratio. When CI < 1, it indicates a synergistic effect, and the lower the CI value, the stronger the synergistic effect. Specifically as follows: a combination index CI ≤ 0.3 indicates a strong synergistic effect, 0.3 < CI ≤ 0.7 indicates a synergistic effect, 0.7 < CI ≤ 0.9 indicates a weak synergistic effect; conversely, 1.1 < CI ≤ 1.45 indicates a weak antagonistic effect, 1.45 < CI ≤ 3.3 indicates an antagonistic effect, and CI > 3.3 indicates a strong antagonistic effect.

[0093] CompuSyn software calculates CI based on the Chou-Talalay method, and the specific calculation formula is as follows formula Ⅰ:

[0094]

[0095] Where: D i is the dose of the ith drug in the combination; (D x ) i is the dose of the ith drug required to achieve the same effect when used alone; n is the number of drugs (usually 2).

[0096] Compared with the groups treated with DOP and Spd alone (DOP-L, DOP-H, Spd-L and Spd-H), the Caenorhabditis elegans in the DS-HH group had the longest lifespan, with an average lifespan of 21.2 days, which was 36.8% longer than the control group (15.5 days). The average lifespan of the DOP-L group, DOP-H group, Spd-L group and Spd-H group was only 17.7, 18.9, 17.4 and 18.8 days, respectively, and the natural aging lifespan was extended by 19.8%, 12.2%, 21.8% and 12.8% compared with the control group. In addition, the mortality rate of each group was selected when the mortality rate of the control group was 50%, and the synergy index CI was calculated to be 0.65 (Table 1), indicating a synergistic effect.

[0097] This patent further compared the effects of DS-HH group and 500mg / L DOP treatment group on extending the lifespan of Caenorhabditis elegans. Figure 4 As shown, the effect of DS-HH (21.2 days) in extending the life span of nematodes is higher than that of 500 mg / L DOP (20.5 days). It can be seen that the combined use of DOP and Spd can play a synergistic role and reduce the amount of DOP used by 50%. According to the current market price, the cost of DOP is 1,200 yuan per kilogram (Shanxi Nanba Biochemical Co., Ltd.), while the cost of Spd is 6,500 yuan per kilogram (Xi'an Tianfeng Biotechnology Co., Ltd.). Calculated based on the configuration of 1L of mixed solution, the cost of 500 mg / L DOP is 0.6 yuan, while the cost of the DS-HH composition that can achieve the same effect is 0.4885 yuan, and the cost can be saved by 18.58%. Therefore, the synergistic anti-aging effect of DOP and Spd is not only reflected in the improvement of biological efficacy, but also has economic advantages.

[0098] Example 7

[0099] DOP synergizes with Spd to enhance the anti-oxidative stress capacity of Caenorhabditis elegans

[0100] The synchronized L4 stage N2 wild-type Caenorhabditis elegans were transferred to NGM solid culture medium, and the Caenorhabditis elegans were intervened with the Escherichia coli OP50 suspension of the above-mentioned DS-LL group, DS-LH group, DS-HL group, DS-HH group, DOP-L group, DOP-H group, Spd-L group and Spd-H group for 3 days. Then, they were transferred to NGM culture medium containing 0.1% H2O2. The survival of the nematodes was observed and the number of surviving nematodes was recorded every 1 h until all the nematodes died (n=30). The survival rate and average lifespan of each group of nematodes under oxidative stress conditions were calculated, and the survival curve was drawn.

[0101] The control group was added with Escherichia coli OP50 suspension without DOP and Spd.

[0102] The results are as follows Figure 5 As shown, in the oxidative stress tolerance test, the nematodes in the DS-HH group had the longest lifespan, with an average lifespan of 8.4 h, while the control group had only 4.0 h. The mortality rate of each group when the mortality rate of the control group was 50% was selected, and the synergistic index CI was calculated to be 0.33 (Table 1), indicating a synergistic effect. Compared with the groups treated with DOP and Spd alone (DOP-L, DOP-H, Spd-L and Spd-H), the Caenorhabditis elegans in the DS-HH group had the longest lifespan, with an average lifespan of 8.4 h. The average lifespans of the control group, DOP-L group, DOP-H group, Spd-L group and Spd-H group were only 4.0, 5.1, 6.0, 5.3 and 5.9 h, respectively.

[0103] Example 8

[0104] DOP and Spd enhance the ability of Caenorhabditis elegans to resist heat stress

[0105] The synchronized L4 stage N2 wild-type Caenorhabditis elegans were transferred to NGM solid culture medium, and the Caenorhabditis elegans were intervened with the Escherichia coli OP50 suspension of the above-mentioned DS-LL group, DS-LH group, DS-HL group, DS-HH group, DOP-L group, DOP-H group, Spd-L group and Spd-H group for 3 days. Then, the nematodes were placed in a 37°C incubator, and the survival of the nematodes was observed and the number of surviving nematodes was recorded every 1 h until all the nematodes died (n=30). The survival rate and average lifespan of the nematodes in each group under high temperature stress conditions were calculated, and the survival curve was drawn.

[0106] The control group was added with Escherichia coli OP50 suspension without DOP and Spd.

[0107] The results are as follows Figure 6As shown, in the heat stress tolerance test, the nematodes in the DS-HH group had the longest lifespan, with an average lifespan of 8.5h, while the control group had only 5.6h. The mortality rate of each group when the mortality rate of the control group was 50% was selected, and the synergy index CI was calculated to be 0.50 (Table 1), indicating a synergistic effect. Compared with the groups treated with DOP and Spd alone, the Caenorhabditis elegans in the DS-HH group had the longest lifespan, with an average lifespan of 8.5h. The average lifespans of the control group, DOP-L group, DOP-H group, Spd-L group and Spd-H group were 5.6, 6.7, 7.4, 7.0 and 7.5h, respectively.

[0108] Table 1 Synergistic index CI of DOP and Spd in anti-aging

[0109]

[0110] Example 9

[0111] DOP cooperates with Spd to enhance the motility of Caenorhabditis elegans

[0112] Movement ability can be quantified by measuring the frequency of body bending and head swinging of nematodes. Synchronized L4-stage N2 wild-type Caenorhabditis elegans were transferred to NGM solid medium. After 3 days of intervention with the above-mentioned DS-LL, DS-LH, DS-HL, DS-HH, DOP-L, DOP-H, Spd-L, and Spd-H Escherichia coli OP50 suspensions, the nematodes were transferred to new NGM solid medium and placed in a 20°C incubator. New NGM solid medium was replaced every 2 days. On the 7th day after intervention, 15 nematodes were randomly selected and placed on clean NGM solid medium. The body bending frequency was analyzed by observing and counting the number of sinusoidal movements of the nematodes within 60 seconds. The head swing frequency was determined by the number of times the nematode's head swung from one side to the other in the same period of time.

[0113] The results are as follows Figure 7As shown, in the determination of motor ability, the number of body bends and head swings in the control group within 60 seconds were 18.3 and 35.7 times, respectively. The nematodes in the DS-HH group had the strongest motor ability, with 23.3 and 42.9 body bends and head swings in one minute, respectively, which were 27.74% and 20.15% higher than those in the control group. Compared with the groups treated with DOP and Spd alone, the Caenorhabditis elegans in the DS-HH group had the strongest motor ability, with 23.3 body bends in 60 seconds, while the control group, DOP-L group, DOP-H group, Spd-L group and Spd-H group had 18.3, 19.3, 20.5, 19.6 and 20.0 body bends, respectively. In addition, the number of head swings of C. elegans in the DS-HH group within 60 seconds was 42.9 times, while the number of body bends in the control group, DOP-L group, DOP-H group, Spd-L group, and Spd-H group were 35.7, 36.7, 37.9, 36.9, and 38.4 times, respectively.

[0114] Example 10

[0115] Effects of DOP and Spd on metabolites in Caenorhabditis elegans

[0116] The metabolome analysis of C. elegans in the control, DOP (DOP-H), Spd (Spd-H), and DS (DS-HH) treatment groups was performed as follows (LC-MS): using the Thermo Fisher Scientific UltiMate TM 3000UHPLC was used to detect bioactive compounds. A full scan MS / dd-MS2 Q mass spectrometer was used for data acquisition and equipped with an electrospray ionization source. The sample extract was separated in UPLC Ultimate 3000 using an HSS T3 column (2.1 mm × 100 mm × 1.8 μm) and the temperature was maintained at 40°C. The mobile phase was water containing 0.1% formic acid, and the mobile phase B was acetonitrile containing 0.1% formic acid. The elution conditions were 0-1.5 min (5% B), 1.5-4.0 min (5% B-40% B), 4.0-5.0 min (40% B-95% B), 5.0-6.0 min (95% B), 6.0-6.1 min (95% B), and 6.1-8.0 min (5% B).

[0117] Orthogonal partial least squares discriminant analysis (OPLS-DA) of the C. elegans metabolome showed that clear separation was observed between the control, DOP, Spd, and DS groups, especially between the DS group and the other three groups, highlighting the significant differences in metabolite profiles among the groups ( Figure 8). The VIP score obtained by OPLS-DA was used to quantify the significance of metabolite changes, and VIP>1.0 indicated that the difference of the metabolite in the model had a substantial effect. Metabolites with VIP>1.0 were further screened by the conditions of p<0.05, FC>1.5 or <0.75. Finally, a total of 36 metabolites were screened, mainly related to lipid, carbohydrate, nucleotide and energy metabolism pathways (see Table 2). It is worth noting that compared with the control group, the DOP group and the Spd group had a smaller effect on the metabolites of C. elegans, while the contents of metabolites such as citric acid, 1-linoleoylglycerol, docosapentaenoic acid (DPA), β-nicotinamide mononucleotide (NMN), cyclic adenosine diphosphate ribose, UDP-galactose, 5-hydroxy-3-indoleacetic acid (5-HIAA) and taurine in C. elegans in the DS group increased significantly by more than 7 times, and nicotinamide adenine dinucleotide (NAD+), γ-aminobutyric acid (GABA), xanthine and adenylic acid increased by more than 3 times.

[0118] These significantly increased metabolites are closely related to aging. For example, NMN is the biosynthetic precursor of NAD+, which is a core factor in many metabolic reactions in cells and plays an important role in energy metabolism, DNA repair and gene expression regulation. With age, the level of NAD+ in the body decreases significantly, which is associated with many age-related diseases and aging phenomena. Supplementing with NMN can increase NAD+ levels and activate sirtuin, which is important for improving mitochondrial function and metabolic health, as well as anti-aging. A study published in Nature Communication in 2024 found that the accumulation of mitochondrial DNA mutations in the intestine of mice can promote intestinal aging, and supplementing with NMN can reverse this aging. DPA is a polyunsaturated fatty acid that belongs to the omega-3 fatty acid family and has multiple protective effects on the cardiovascular and nervous systems. Studies have shown that DPA can reduce triglyceride levels in the blood, reduce the risk of atherosclerosis, and improve endothelial function, which helps prevent cardiovascular disease. GABA is the main inhibitory neurotransmitter of the central nervous system. With age, the content of GABA in the brain decreases, which is associated with cognitive decline. GABA plays a key role in regulating neural excitability and maintaining the balance of neuronal activity, and is particularly important in preventing age-related neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.

[0119] Table 2 Metabolites that changed significantly after DOP and Spd treatment

[0120]

[0121]

[0122] The embodiments provided above are not intended to limit the scope of the present invention, and the steps described are not intended to limit the execution order thereof. Those skilled in the art may make obvious improvements to the present invention in combination with existing common knowledge, which also fall within the scope of protection defined by the claims of the present invention.

Claims

1. A composition containing Dendrobium officinale polysaccharide, characterized in that: The composition comprises dendrobium officinale polysaccharide and spermidine; the concentration of the dendrobium officinale polysaccharide in the composition is 240-260 mg / L, and the concentration of spermidine is 25-35 mg / L.

2. The composition according to claim 1, characterized in that The concentration of Dendrobium officinale polysaccharide in the composition is 250 mg / L; the concentration of spermidine in the composition is 29 mg / L.

3. The composition according to claim 1, characterized in that The solvent of the composition includes water and ethanol aqueous solution.

4. The composition according to claim 1, characterized in that The composition may further include auxiliary materials; the auxiliary materials include one or more of nutrients, functional additives, and flavor additives.

5. The composition according to claim 1, characterized in that The preparation method of the Dendrobium officinale polysaccharide is as follows: The powder of Dendrobium officinale is defatted, and then washed with ethanol to remove impurities, and then the washed powder of Dendrobium officinale is extracted with hot water, and the obtained extract is precipitated with ethanol aqueous solution; the precipitate obtained by centrifugation is resuspended and destarchized with thermostable α-amylase, and then freeze-thaw centrifugation is performed; The obtained supernatant is dialyzed, and then the dialyzate is precipitated using an ethanol aqueous solution, and the precipitate is collected and freeze-dried to obtain Dendrobium officinale polysaccharide.

6. The composition according to claim 1, characterized in that The temperature of the hot water extraction is 90-95° C., and the time is 4-6 hours.

7. The composition according to claim 1, characterized in that The enzyme activity of the heat-resistant α-amylase is 15000-25000 U / mL; the ratio of the mass of the precipitate to the volume of the heat-resistant α-amylase is 8-12 g:0.5 mL.

8. The composition according to claim 1, characterized in that The dialysis is performed in a 3000-4000Da dialysis bag for 60-80 hours.

9. Use of the composition according to any one of claims 1 to 8 in the field of drug preparation, health care products or functional foods.

10. The use according to claim 9, characterized in that The medicine is a medicine that has the effect of delaying aging and preventing Alzheimer's disease and / or Parkinson's disease; the health care product is a health care product that helps to resist oxidation or assists in improving memory.

Citation Information

Cited By

  • Application of dendrobium polysaccharide in preparation of medicine for preventing and / or treating neuroinflammation caused by alcohol and dendrobium polysaccharide liqueur

    CN120501759A